title: Intravenous administration of achyranthes bidentata polypeptides supports recovery from experimental ischemic stroke in vivo.
abstract: BACKGROUND
  Achyranthes bidentata Blume (A. bidentata) is a commonly prescribed Chinese medicinal herb. A. bidentata polypeptides (ABPP) is an active composite constituent, separated from the aqueous extract of A. bidentata. Our previous studies have found that ABPP have the neuroprotective function in vitro and in rat middle cerebral artery occlusion (MCAO) model in attenuating the brain infract area induced by focal ischemia-reperfusion. However, the ultimate goal of the stroke treatment is the restoration of behavioral function. Identifying behavioral deficits and therapeutic treatments in animal models of ischemic stroke is essential for potential translational applications.
  
  
  RESULTS
  The effect of ABPP on motor, sensory, and cognitive function in an ischemic stroke model with MCAO was investigated up to day 30. The function recovery monitored by the neurological deficit score, grip test, body asymmetry, beam-balancing task, and the Morris Water Maze. In this study, systemic administration of ABPP by i.v after MCAO decreased the neurological deficit score, ameliorated the forepaw muscle strength, and diminished the motor and sensory asymmetry on 7(th) and 30(th) day after MCAO. MCAO has been observed to cause prolonged disturbance of spatial learning and memory in rats using the MWM, and ABPP treatment could improve the spatial learning and memory function, which is impaired by MCAO in rats, on 30(th) day after MCAO. Then, the viable cells in CA1 region of hippocampus were counted by Nissl staining, and the neuronal cell death were significantly suppressed in the ABPP treated group.
  
  
  CONCLUSIONS
  ABPP could improve the recovery of sensory, motor and coordination, and cognitive function in MCAO-induced ischemic rats. And this recovery had a good correlation to the less of neuronal injury in brain.
authors.affiliation: Key Laboratory of Neuroregeneration and Institute of Nautical Medicine, Nantong University, Nantong, China. hmshen1971@gmail.com
authors.forename: Hongmei
authors.initials: H
authors.lastname: Shen
authors.forename: Xinmin
authors.initials: X
authors.lastname: Wu
authors.forename: Yuzhong
authors.initials: Y
authors.lastname: Zhu
authors.forename: Hualing
authors.initials: H
authors.lastname: Sun
mesh_terms: D029044:Achyranthes / Q000737:chemistry*; D061605:Administration, Intravenous; D000818:Animals; D002544:Cerebral Infarction / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D004195:Disease Models, Animal; D007858:Learning / Q000187:drug effects; D008297:Male; D008568:Memory / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000473:pathology; D018696:Neuroprotective Agents / Q000008:administration & dosage; D010455:Peptides / Q000008:administration & dosage*; D011597:Psychomotor Performance / Q000187:drug effects; D051381:Rats; D020521:Stroke / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D013697:Thermosensing / Q000187:drug effects
chemical_list: D018696:Neuroprotective Agents; D010455:Peptides